메뉴 건너뛰기




Volumn 86, Issue 2, 2012, Pages 359-372

The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: Systematic review

Author keywords

[No Author keywords available]

Indexed keywords

YELLOW FEVER VACCINE;

EID: 84856997228     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.11-0525     Document Type: Article
Times cited : (73)

References (46)
  • 1
    • 77949702062 scopus 로고    scopus 로고
    • Yellow fever vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • Centers for Disease Control and Prevention (CDC), July 30, 2010
    • Staples JE, Gershman M, Fischer M, Centers for Disease Control and Prevention (CDC), 2010. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep Recommendations. July 30, 2010/Vol 59/No. RR-7, 1-27.
    • (2010) MMWR Morb Mortal Wkly Rep Recommendations , vol.59 , Issue.RR-7 , pp. 1-27
    • Staples, J.E.1    Gershman, M.2    Fischer, M.3
  • 2
    • 85159011903 scopus 로고    scopus 로고
    • Yellow fever vaccine
    • Plotkin SA, Orenstein WA, Offit PA, eds. 5th ed. Philadelphia, PA: W.B. Saunders
    • Monath TP, Cetron MS, Teuwen DE, 2008. Yellow fever vaccine. Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines, 5th ed. Philadelphia, PA: W.B. Saunders, 959-1055.
    • (2008) Vaccines , pp. 959-1055
    • Monath, T.P.1    Cetron, M.S.2    Teuwen, D.E.3
  • 3
    • 0345657167 scopus 로고    scopus 로고
    • WHO Emerging and Other CommunicableDiseases, Geneva, Switzerland: World Health Organization
    • WHO Emerging and Other CommunicableDiseases, 1998. District Guidelines for Yellow Fever Surveillance. Geneva, Switzerland: World Health Organization.
    • (1998) District Guidelines for Yellow Fever Surveillance
  • 4
    • 0343103345 scopus 로고
    • WHO Division of Epidemiological Surveillance and Health Situation Trend Assessment, Geneva, Switzerland: World Health Organization
    • WHO Division of Epidemiological Surveillance and Health Situation Trend Assessment, 1992. Global Health Situation and Projections - Estimates. Geneva, Switzerland: World Health Organization.
    • (1992) Global Health Situation and Projections - Estimates
  • 6
    • 33947124138 scopus 로고    scopus 로고
    • 17D yellow fever vaccines: New insights. A report of a workshop held during the World Congress on Medicine and Health in the Tropics, Marseille, France, Monday 12 September 2005
    • DOI 10.1016/j.vaccine.2006.12.015, PII S0264410X0601334X
    • Barrett AD, Monath TP, Barban V, Niedrig M, Teuwen DE, 2007. 17D yellow fever vaccines: new insights.Areport of a workshop held during the World Congress on Medicine and Health in the Tropics, Marseille, France,Monday 12 September 2005. Vaccine 25: 2758-2765. (Pubitemid 46412570)
    • (2007) Vaccine , vol.25 , Issue.15 , pp. 2758-2765
    • Barrett, A.D.T.1    Monath, T.P.2    Barban, V.3    Niedrig, M.4    Teuwen, D.E.5
  • 8
    • 0003864029 scopus 로고    scopus 로고
    • Available at: Accessed October 9, 2011
    • World Health Organization, 2011. International Travel and Health. Available at: http://www.who.int/ith/chapters/en/index.html. Accessed October 9, 2011.
    • (2011) International Travel and Health
  • 9
    • 34447287275 scopus 로고    scopus 로고
    • Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): Case definitions and guidelines for collection, analysis and presentation of immunization safety data
    • Brighton Collaboration Encephalitis Working Group
    • Sejvar JJ,KohlKS,Bilynsky R, Blumberg D,Cvetkovich T,Galama J, Gidudu J, Katikaneni L,Khuri-Bulos N, Oleske J, Tapianen T, Wiznitzer M, Brighton Collaboration Encephalitis Working Group, 2007. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis and presentation of immunization safety data. Vaccine 25: 5771-5792.
    • (2007) Vaccine , vol.25 , pp. 5771-5792
    • Sejvar, J.J.1    Kohl, K.S.2    Bilynsky, R.3    Blumberg, D.4    Cvetkovich, T.5    Galama, J.6    Gidudu, J.7    Katikaneni, L.8    Khuri-Bulos, N.9    Oleske, J.10    Tapianen, T.11    Wiznitzer, M.12
  • 15
    • 6344278186 scopus 로고    scopus 로고
    • Age-related risk of adverse events following yellow fever vaccination in Australia
    • Lawrence GL, Burgess MA, Kass RB, 2004. Age-related risk of adverse events following yellow fever vaccination in Australia. Commun Dis Intell 28: 244-248.
    • (2004) Commun Dis Intell , vol.28 , pp. 244-248
    • Lawrence, G.L.1    Burgess, M.A.2    Kass, R.B.3
  • 21
    • 0026281258 scopus 로고
    • Ėtude d'un nouveau vaccin combiné contre la fièvre jaune et la rougeole chez les enfants agés de 6 au 24 mois au Mali
    • Soula G, Sylla A, Pichard E, Kodio B, Bentejac MC, Teulieres L, Saliou P, 1991. Ėtude d'un nouveau vaccin combiné contre la fièvre jaune et la rougeole chez les enfants agés de 6 au 24 mois au Mali. Bull Soc Pathol Exot 84: 885-897.
    • (1991) Bull Soc Pathol Exot , vol.84 , pp. 885-897
    • Soula, G.1    Sylla, A.2    Pichard, E.3    Kodio, B.4    Bentejac, M.C.5    Teulieres, L.6    Saliou, P.7
  • 23
    • 80955179052 scopus 로고
    • Encephalitis after yellow fever vaccination
    • Cannon D, 1955. Encephalitis after yellow fever vaccination. BMJ 1: 1090.
    • (1955) BMJ , vol.1 , pp. 1090
    • Cannon, D.1
  • 24
    • 76749123835 scopus 로고    scopus 로고
    • Transmission of yellow fever vaccine virus through breast feeding - Brazil 2009
    • Couto AM, 2010. Transmission of yellow fever vaccine virus through breast feeding - Brazil 2009. MMWR Morb Mortal Wkly Rep 59: 130-132.
    • (2010) MMWR Morb Mortal Wkly Rep , vol.59 , pp. 130-132
    • Couto, A.M.1
  • 25
    • 79952319151 scopus 로고    scopus 로고
    • Case report: Probable transmission of vaccine strain of yellow fever virus to an infant via breast milk
    • Kuhn S, Twele-Montecinos L, MacDonald J, Webster P, Law B, 2011. Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk. CMAJ 183: E243-E245.
    • (2011) CMAJ , vol.183
    • Kuhn, S.1    Twele-Montecinos, L.2    MacDonald, J.3    Webster, P.4    Law, B.5
  • 26
    • 84861149174 scopus 로고    scopus 로고
    • Global Advisory Committee on Vaccine Safety
    • Global Advisory Committee on Vaccine Safety, 2010. Wkly Epidemiol Rec 85: 285-291.
    • (2010) Wkly Epidemiol Rec , vol.85 , pp. 285-291
  • 27
    • 34347223245 scopus 로고    scopus 로고
    • Early exposure to yellow fever vaccine during pregnancy
    • Campinas Group of Yellow Fever Immunization during Pregnancy
    • Cavalcanti DP, Salomão MA, Lopez-Camelo J, Pessoto MA, Campinas Group of Yellow Fever Immunization during Pregnancy, 2007. Early exposure to yellow fever vaccine during pregnancy. Trop Med Int Health 12: 833-837.
    • (2007) Trop Med Int Health , vol.12 , pp. 833-837
    • Cavalcanti, D.P.1    Salomão, M.A.2    Lopez-Camelo, J.3    Pessoto, M.A.4
  • 31
    • 40849126861 scopus 로고    scopus 로고
    • Impact of vaccines given during pregnancy on the offspring of women consulting a travel clinic: A longitudinal study
    • DOI 10.1111/j.1708-8305.2007.00175.x
    • D'Acremont V, Tremblay S, Genton B, 2008. Impact of vaccines given during pregnancy on the offspring of women consulting a travel clinic: a longitudinal study. J Travel Med 15: 77-81. (Pubitemid 351393027)
    • (2008) Journal of Travel Medicine , vol.15 , Issue.2 , pp. 77-81
    • D'Acremont, V.1    Tremblay, S.2    Genton, B.3
  • 33
    • 0345337263 scopus 로고    scopus 로고
    • Exposure to yellow fever vaccine in early pregnancy
    • DOI 10.1016/S0264-410X(98)00051-6, PII S0264410X98000516
    • Robert E, Vial T, Schaefer C, Arnon J, Reuvers M, 1999. Exposure to yellow fever vaccine in early pregnancy. Vaccine 17: 283-285. (Pubitemid 28552788)
    • (1999) Vaccine , vol.17 , Issue.3 , pp. 283-285
    • Robert, E.1    Vial, T.2    Schaefer, C.3    Arnon, J.4    Reuvers, M.5
  • 34
  • 36
    • 0000180559 scopus 로고
    • Good tolerance and efficacy of yellow fever vaccine among carriers of human immunodeficiency virus
    • Goujon C, Tohr M, Feuillie V, Coulaud P, Dupont B, Sansonetti P, 1995. Good tolerance and efficacy of yellow fever vaccine among carriers of human immunodeficiency virus. J Travel Med 2: 145.
    • (1995) J Travel Med , vol.2 , pp. 145
    • Goujon, C.1    Tohr, M.2    Feuillie, V.3    Coulaud, P.4    Dupont, B.5    Sansonetti, P.6
  • 43
    • 0036334816 scopus 로고    scopus 로고
    • Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection
    • Kengsakul K, Sathirapongsasuti K, Punyagupta S, 2002. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. JMed Assoc Thai 85: 131-134.
    • (2002) JMed Assoc Thai , vol.85 , pp. 131-134
    • Kengsakul, K.1    Sathirapongsasuti, K.2    Punyagupta, S.3
  • 44
    • 74849116505 scopus 로고    scopus 로고
    • Yellow fever vaccination in HIV-infected patients
    • Veit O, Hatz C, Niedrig M, Furrer H, 2010. Yellow fever vaccination in HIV-infected patients. HIV Ther 4: 17-26.
    • (2010) HIV Ther , vol.4 , pp. 17-26
    • Veit, O.1    Hatz, C.2    Niedrig, M.3    Furrer, H.4
  • 45


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.